Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Recruiting Phase 2 Trials for Osimertinib (DB09330)

IndicationStatusPhase
DBCOND0115716 (Stage IIIB Lung Non-Small Cell Cancer AJCC v7)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs